ZETEZE ezetimibe/atorvastatin 10mg/20mg tablet blister pack

Negara: Australia

Bahasa: Inggris

Sumber: Department of Health (Therapeutic Goods Administration)

Bahan aktif:

atorvastatin calcium trihydrate, Quantity: 21.7 mg (Equivalent: atorvastatin, Qty 20 mg); ezetimibe, Quantity: 10 mg

Tersedia dari:

ORGANON PHARMA PTY LTD

INN (Nama Internasional):

atorvastatin calcium trihydrate,Ezetimibe

Bentuk farmasi:

Tablet, multilayer

Komposisi:

Excipient Ingredients: polysorbate 80; magnesium stearate; povidone; lactose monohydrate; sodium lauryl sulfate; croscarmellose sodium; microcrystalline cellulose; calcium carbonate; hyprolose; silicon dioxide; titanium dioxide; macrogol 8000; hypromellose; purified talc

Rute administrasi :

Oral

Unit dalam paket:

10, 30

Jenis Resep:

(S4) Prescription Only Medicine

Indikasi Terapi:

Prevention of Cardiovascular Disease ZETEZE is indicated in patients with coronary heart disease (CHD) and a history of acute coronary syndrome (ACS) taking their maximum tolerated dose of atorvastatin and in need of additional lowering of LDL-C in the expectation of a modest further reduction in the risk of cardiovascular events following at least one year of therapy (see Clinical Trials). Primary Hypercholesterolaemia ZETEZE is indicated as adjunctive therapy to diet in patients with primary (heterozygous familial and non-familial) hypercholesterolaemia where use of a combination product is appropriate in those patients: - not appropriately controlled with atorvastatin or ezetimibe alone; - or already treated with atorvastatin and ezetimibe Homozygous Familial Hypercholesterolaemia (HoFH) ZETEZE is indicated in patients with HoFH. Patients may also receive adjunctive treatments (e.g. LDL apheresis).

Ringkasan produk:

Visual Identification: Capsule shaped, biconvex, white to off white tablets, with "333" debossed on one side of the tablet; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius

Status otorisasi:

Licence status A

Tanggal Otorisasi:

2015-02-04